Prof. Fernando López-Ríos (NTRK CONNECT) has developed this resource with COR2ED.
Prof. Fernando López-Ríos (NTRK CONNECT) has developed this resource with COR2ED.
Fernando Lopez-Rios is the Chief of the Molecular Diagnostics Service at Hospital Universitario 12 de Octubre (Madrid) and Professor of Pathology at Universidad Complutense (Madrid).
Dr Lopez-Rios has also been the Director of the Therapeutic Targets Laboratory at HM Hospitales (Spain) and a visiting researcher at Memorial Sloan Kettering Cancer Center (New York).
He is the 2023 recipient of the Mary J. Matthews Pathology & Transitional Research Award (International Association for the Study of Lung Cancer, IASLC) and the Deputy Chair of the IASLC Pathology Committee.
His main clinical and research expertise is in cancer biomarker testing.
Honoraria: AbbVie, AstraZeneca, Bayer, BMS, Boehringer Ingelheim, Daiichi Sankyo, Janssen, Lilly, MSD, Pfizer, Regeneron, Roche, and Thermo Fisher.
Research support: AstraZeneca, Janssen, Lilly, Pfizer, Roche, and Thermo Fisher.
Understanding EP-NEC, emerging treatments, and patient care strategies
Strategies to optimise the treatment experience
Coming soon! Expert insights on the latest data
On-demand materials from an Experts Knowledge Share event